30
Participants
Start Date
November 30, 2003
Study Completion Date
June 30, 2004
Xcellerated T Cells
Center for Cancer & Blood Disorders, Bethesda
Johns Hopkins Medical Institute, Baltimore
Cancer Centers of the Carolinas, Greenville
Washington University School of Medicine, St Louis
Oncotherapeutics, Los Angeles
University of California, San Diego, San Diego
University of California, San Francisco, San Francisco
Oregon Health Sciences University, Portland
Hackensack University Medical Center, Hackensack
Lead Sponsor
Xcyte Therapies
INDUSTRY